Cover Image for Will AI Scientists solve drug R&D, or just make it faster?

Presented by

Owkin is an AI company unlocking complex biology. At its core is K Pro, an AI scientist for biology powered by patient data and biological reasoning to drive breakthroughs in research.

Hosted By

Private Event

Will AI Scientists solve drug R&D, or just make it faster?

Owkin

Register to See Address

San Francisco, CA

Approval Required

Your registration is subject to host approval.

Welcome! To join the event, please register below.

You will be asked to verify token ownership with your wallet.

About Event

Hosted by Owkin & AWS

Join us for an invite-only panel discussion and networking event exploring one of the most important questions facing the future of drug R&D: Will AI Scientists truly solve the underlying challenges that have constrained drug discovery and development for decades, or will they simply make existing processes faster and more efficient?

What’s on the agenda?

6:30 PM — Arrival & Welcome
7:00–7:45 PM — Expert Panel: Will AI Scientists solve Drug R&D, or simply make it faster?
8:00–10:00 PM — Networking Reception with drinks & canapés

Panelists

Pascal Weinberger - Deputy CEO, Owkin
Sam Rodrigues - Co-Founder and CEO, FutureHouse and Edison Scientific
James Zou - Associate Professor of Biomedical Data Science, Stanford University
Vivek Natarajan - AI Researcher, Google

More panelists to be announced soon.

Attendance is limited and available by invitation only.

Location

Please register to see the exact location of this event.

San Francisco, CA

Presented by

Owkin

Owkin is an AI company unlocking complex biology. At its core is K Pro, an AI scientist for biology powered by patient data and biological reasoning to drive breakthroughs in research.

Hosted By